Results for tag: "Nucleotide"

In biotechnology, the nucleotide market encompasses the production and sale of nucleotides, which are the basic building blocks of nucleic acids, namely DNA and RNA. This market serves a diverse array of applications including research, pharmaceuticals, diagnostics, and agricultural biotechnology. The synthesis of custom nucleotides enables advancements in genetic engineering, gene sequencing, and personalized medicine. Companies in this sector often provide both individual nucleotides for research and therapeutic purposes as well as oligonucleotides, which are short sequences of nucleotides synthesized to match specific DNA or RNA sequences for use in experiments or as drugs. The demand in this market is driven by the expanding understanding of genetic material and the increasing applicability of nucleic acid-based technologies. Environmental concerns and regulations also influence the production and sale of nucleotides. Key players in the nucleotide market include Thermo Fisher Scientific, a prominent provider of scientific instrumentation and reagents; Sigma-Aldrich (now part of Merck KGaA), known for chemicals and nucleotides for research purposes; Illumina, which specializes in sequencing and array-based technologies; and Integrated DNA Technologies, providing custom nucleic acids for various applications. Other notable companies include Agilent Technologies, which provides analytical instruments and services to the life sciences industry; and Eurofins Genomics, a leader in genomic services. Show Less Read more